• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Mycophenolate as a corticoid saver in a patient with pneumonia organized by COVID-19].

作者信息

Esteve Gimeno M J, Roig Martí C, Pérez Catalán I, Tornador Gaya N, Usó Blasco J

机构信息

María José Esteve Gimeno, Servicio de Medicina Interna del Hospital General de Castellón. Avenida Benicassim s/n. Spain.

出版信息

Rev Esp Quimioter. 2021 Dec;34(6):672-674. doi: 10.37201/req/048.2021. Epub 2021 Sep 29.

DOI:10.37201/req/048.2021
PMID:34585563
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8638764/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f0/8638764/3d49575bb3f5/revespquimioter-34-672-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f0/8638764/08246a984000/revespquimioter-34-672-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f0/8638764/3d49575bb3f5/revespquimioter-34-672-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f0/8638764/08246a984000/revespquimioter-34-672-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f0/8638764/3d49575bb3f5/revespquimioter-34-672-g002.jpg

相似文献

1
[Mycophenolate as a corticoid saver in a patient with pneumonia organized by COVID-19].[霉酚酸作为新型冠状病毒肺炎所致机化性肺炎患者糖皮质激素减量剂的应用]
Rev Esp Quimioter. 2021 Dec;34(6):672-674. doi: 10.37201/req/048.2021. Epub 2021 Sep 29.
2
The proper use of corticosteroids for 2019-nCov pneumonia: Towards promising results?2019新型冠状病毒肺炎中皮质类固醇的合理使用：能否取得理想效果？
J Infect. 2021 Jan;82(1):e6-e7. doi: 10.1016/j.jinf.2020.08.001. Epub 2020 Aug 5.
3
A Role for Steroids in COVID-19-associated Pneumonitis at Six-Week Follow-Up?类固醇在新冠病毒相关肺炎六周随访中起作用？
Ann Am Thorac Soc. 2021 Jun;18(6):1082-1083. doi: 10.1513/AnnalsATS.202101-048LE.
4
Organizing pneumonia: A late phase complication of COVID-19 responding dramatically to corticosteroids.机化性肺炎：COVID-19 的晚期并发症，对皮质类固醇反应剧烈。
Braz J Infect Dis. 2021 Jan-Feb;25(1):101541. doi: 10.1016/j.bjid.2021.101541. Epub 2021 Feb 6.
5
Reply to: "Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients".回复：“年龄和合并症是肝移植受者死于COVID-19风险的关键因素”。
J Hepatol. 2021 Jul;75(1):228-229. doi: 10.1016/j.jhep.2021.04.005. Epub 2021 Apr 20.
6
The Uncertain Role of Corticosteroids in the Treatment of COVID-19.皮质类固醇在治疗新型冠状病毒肺炎中的不确定作用
JAMA Intern Med. 2021 Jan 1;181(1):140. doi: 10.1001/jamainternmed.2020.2444.
7
[COVID-19 and asthma].[新型冠状病毒肺炎与哮喘]
Rev Med Liege. 2020;75(S1):130-132.
8
Topical steroids and topical tacrolimus appear safe regarding the COVID-19 epidemic.就新冠疫情而言，外用类固醇和外用他克莫司似乎是安全的。
Ann Dermatol Venereol. 2021 Jun;148(2):122-123. doi: 10.1016/j.annder.2020.12.001. Epub 2021 Jan 8.
9
Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19.低剂量皮质类固醇疗法不会延迟新冠病毒疾病患者的病毒清除。
J Infect. 2020 Jul;81(1):147-178. doi: 10.1016/j.jinf.2020.03.039. Epub 2020 Apr 11.
10
COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?新型冠状病毒肺炎、哮喘与吸入性糖皮质激素：吸入性糖皮质激素的又一有益作用？
Am J Respir Crit Care Med. 2020 Jul 1;202(1):8-10. doi: 10.1164/rccm.202005-1651ED.

本文引用的文献

1
Sustained coronavirus disease 2019-related organizing pneumonia successfully treated with corticosteroid.持续的 COVID-19 相关机化性肺炎经皮质类固醇治疗成功。
Respir Investig. 2021 May;59(3):377-381. doi: 10.1016/j.resinv.2020.12.005. Epub 2021 Jan 21.
2
Radiologic aspects of COVID-19 pneumonia: outcomes and thoracic complications.COVID-19 肺炎的放射学表现：结局和胸部并发症。
Radiologia (Engl Ed). 2021 Jan-Feb;63(1):74-88. doi: 10.1016/j.rx.2020.11.002. Epub 2020 Nov 25.
3
Dexamethasone in Hospitalized Patients with Covid-19.
地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
4
Personalized Therapy Approach for Hospitalized Patients with Coronavirus Disease 2019.个体化治疗方案在 2019 冠状病毒病住院患者中的应用
Clin Infect Dis. 2022 Jan 7;74(1):127-132. doi: 10.1093/cid/ciaa964.
5
Radiology-Pathology Correlation Demonstrating Organizing Pneumonia in a Patient Who Recovered from COVID-19.放射学与病理学相关性研究显示一名从新冠病毒疾病中康复的患者出现机化性肺炎。
Am J Respir Crit Care Med. 2020 Aug 15;202(4):598-599. doi: 10.1164/rccm.202004-1278IM.
6
Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection.是时候考虑肺损伤的组织学模式来治疗新冠肺炎感染的重症患者了。
Intensive Care Med. 2020 Jun;46(6):1124-1126. doi: 10.1007/s00134-020-06057-8. Epub 2020 Apr 23.
7
Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies.通过尸体核心活检对 2019 年新型冠状病毒病（COVID-19）的病理学研究。
Mod Pathol. 2020 Jun;33(6):1007-1014. doi: 10.1038/s41379-020-0536-x. Epub 2020 Apr 14.
8
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
9
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
10
[Diagnosis and treatment of diffuse interstitial lung diseases].[弥漫性间质性肺疾病的诊断与治疗]
Arch Bronconeumol. 2003 Dec;39(12):580-600. doi: 10.1016/s0300-2896(03)75457-x.